Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue 8, 2008, Pages 635-641

  Honkanen, Jarno ^a   Skarsvik, Susanne ^b   Knip, Mikael ^c,d   Vaarala, Outi ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Naive T cell; Quantitative RT PCR; Regulatory T cell; T helper cells; Type 1 diabetes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GENE PRODUCT; INDUCIBLE COSTIMULATOR PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 5; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; INTERLEUKIN 4; MESSENGER RNA; NFATC1 PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN;

ARTICLE; CELL POLARITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; UPREGULATION; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; T LYMPHOCYTE;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CHILD; CYTOKINES; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 60849119592     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.904     Document Type: Article

References (24)

1. Cox NJ, Wapelhorst B, Morrison VA, et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet 2001; 69(4): 820-830.
2. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85(3): 311-318.
3. Bendelac A, Carnaud C, Boitard C, Bach JF. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T-cells. J Exp Med 1987; 166(4): 823-832.
4. Juedes AE, von Herrath MG. Regulatory T-cells in type 1 diabetes. Diabetes Metab Res Rev 2004; 20(6): 446-451.
5. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25+ regulatory T-cells. Nat Immunol 2003; 4(4): 330-336.
6. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T-cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005; 6(4): 331-337.
7. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+ CD25+ T regulatory cells. Nat Immunol 2003; 4(4): 337-342.
8. Sakaguchi S. Naturally arising Foxp3-expressing CD25 + CD4+ regulatory T-cells in immunological tolerance to self and nonself. Nat Immunol 2005; 6(4): 345-352.
9. Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25 + CD4+ regulatory T-cells. Int Immunol 2004; 16(11): 1643-1656.
10. Morgan ME, van Bilsen JH, Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4 + CD25+ T regulatory cells in humans. Hum Immunol 2005; 66(1): 13-20.
11. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al. Human CD4+ CD25hi Foxp3+ regulatory T-cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006; 116(9): 2423-2433.
12. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FOXP3-mutant human T-cells: FOXP3 expression without regulatory T-cell development. Proc Natl Acad Sci U S A 2006; 103(17): 6659-6664.
13. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T-cells. Eur J Immunol 2007; 37(1): 129-138.
14. Halminen M, Klemetti P, Vaarala O, Hurme M, Ilonen J. Interferon-gamma production in antigen specific T-cell response: quantitation of specific mRNA and secreted protein. Scand J Immunol 1997; 46(4): 388-392.
15. Roncador G, Brown PJ, Maestre L, et al. Analysis of FOXP3 protein expression in human CD4 + CD25+ regulatory T-cells at the single-cell level. Eur J Immunol 2005; 35(6): 1681-1691.
16. Ziegler SF. FOXP3: not just for regulatory T-cells anymore. Eur J Immunol 2007; 37(1): 21-23.
17. Mantel PY, Ouaked N, Ruckert B, et al. Molecular mechanisms underlying FOXP3 induction in human T-cells. J Immunol 2006; 176(6): 3593-3602.
18. Wu Y, Borde M, Heissmeyer V, et al. FOXP3 controls regulatory T-cell function through cooperation with NFAT. Cell 2006; 126(2): 375-387.
19. Mesturini R, Nicola S, Chiocchetti A, et al. ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naive CD4+ T-cells. Eur J Immunol 2006; 36(10): 2601-2612.
20. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005; 54(1): 92-99.
21. Putnam AL, Vendrame F, Dotta F, Gottlieb PA. CD4 + CD25high regulatory T-cells in human autoimmune diabetes. J Autoimmun 2005; 24(1): 55-62.
22. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 2005; 115(7): 1953-1962.
23. Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 1991; 165(2): 97-103.
24. Huang X, Yuang J, Goddard A, et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995; 44(6): 658-664.